Published: Friday, December 2nd, 2011
Golden Jubilee – the busiest thoracic centre in UK and Ireland
The Golden Jubilee National Hospital has welcomed a recent report by the Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS) which states that more than 3,500 thoracic (lung) procedures were carried out in Glasgow over a three year period - more than anywhere else in Great Britain or Ireland.
The Second National Thoracic Surgery Activity and Outcomes Report 2011, issued by SCTS earlier this month, provides data relating to a three-year period of thoracic surgical activity from the beginning of April 2006 to the end of March 2009 (financial years ending 2007-2009).
Forty surgical hospitals contributed to the report and at least 98% of the thoracic procedures during this time have been captured for analysis. Glasgow's early figures include data from the Western and Royal Infirmaries and Lanarkshire's Hairmyres Hospital but from May 2008 all adult heart and lung surgery transferred to the Golden Jubilee National Hospital.
As well as having the greatest overall activity for the period, Glasgow's thoracic centre:
performed the highest number of major procedures (over 2,500);carried out the highest number of lung resections (over 1,300) which included the highest number for primary cancer (over 1,000);performed the most mediastinoscopy/ mediastinotomy procedures to obtain biopsies for primary lung cancer (over 650); andcompleted over 300 pneumothorax, or collapsed lung, surgeries – second only to Guy's and St Thomas' hospital in London.
On hearing these figures, Alan Kirk, Cardiothoracic Consultant and Thoracic Surgical Audit Lead at the Golden Jubilee National Hospital, said: "Our specialist centre at the Golden Jubilee National Hospital is one of the largest heart and lung units in the UK, and it is excellent to have the high volume of thoracic procedures we carry out here confirmed in this report.
"The concentration of resources, skills and expertise within the centre allows us to lead the way in terms of research, development and academic activity which ensures innovation and improvements in patient care.
"Surgical treatment for lung cancer and other thoracic diseases is undoubtedly improving and this, in turn, will lead to better survival rates in the future."
Date of release: Friday 2 December 2011